Methenamine Hippurate (CAT: R047410) is a compound utilized for urinary tract antiseptic purposes. Upon administration, methenamine is broken down into formaldehyde and ammonia in the acidic environment of the urinary tract, thereby creating an inhospitable environment for bacterial growth. This pharmacological action makes it valuable in preventing recurrent urinary tract infections. Methenamine hippurate specifically combines methenamine with hippuric acid to improve its solubility and effectiveness. It serves as a therapeutic agent in managing and prophylactically addressing lower urinary tract infections, offering an alternative treatment option to combat bacterial proliferation.
| Catalog Number | R047410 |
| CAS Number | 5714-73-8 |
| Synonyms | 1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane N-Benzoylglycine; Hexamethylenetetramine Monohippurate; Haiprex; Hexamethylenetetramine Hippurate; Hexamethylenetetramine Hippuric Acid Complex; Hippramine; Hiprex; R-657; Urex; Viapta; |
| Molecular Formula | C15H21N5O3 |
| Purity | ≥95% |
| Storage | -20°C |
| InChI | InChI=1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2 |
| InChIKey | ROAIXOJGRFKICW-UHFFFAOYSA-N |
| SMILES | C1N2CN3CN1CN(C2)C3.C1=CC=C(C=C1)C(=O)NCC(=O)O |
